Miao LY - Search Results

1

The effect of first-in-class small molecule RhoA inhibitor, HL07, on the phenylephrine-induced artery contraction.

Zhang Y, Deng J, Ma S, Xue L, Zhu J, Zhu WL, Jiang HL, Li J, Miao LY. Zhang Y, et al. Among authors: miao ly. Curr Pharm Des. 2012;18(27):4258-64. doi: 10.2174/138161212802430387. Curr Pharm Des. 2012. PMID: 22621254

2

[Population pharmacokinetic study of tacrolimus in patients with hematopoietic stem cell transplant].

Xue L, Rui JZ, Zhang Y, Miao LY. Xue L, et al. Among authors: miao ly. Yao Xue Xue Bao. 2009 Oct;44(10):1145-51. Yao Xue Xue Bao. 2009. PMID: 20055140 Chinese.

3

Strong association between HLA-B*1502 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients.

Zhang Y, Wang J, Zhao LM, Peng W, Shen GQ, Xue L, Zheng XX, He XJ, Gong CY, Miao LY. Zhang Y, et al. Among authors: miao ly. Eur J Clin Pharmacol. 2011 Sep;67(9):885-7. doi: 10.1007/s00228-011-1009-4. Epub 2011 Mar 19. Eur J Clin Pharmacol. 2011. PMID: 21424386

4

Design and synthesis of small molecule RhoA inhibitors: a new promising therapy for cardiovascular diseases?

Deng J, Feng E, Ma S, Zhang Y, Liu X, Li H, Huang H, Zhu J, Zhu W, Shen X, Miao L, Liu H, Jiang H, Li J. Deng J, et al. J Med Chem. 2011 Jul 14;54(13):4508-22. doi: 10.1021/jm200161c. Epub 2011 Jun 7. J Med Chem. 2011. PMID: 21615130

5

Population pharmacokinetics and pharmacogenetics of tacrolimus in healthy Chinese volunteers.

Xue L, Zhang H, Ma S, Rui JZ, Miao LY. Xue L, et al. Among authors: miao ly. Pharmacology. 2011;88(5-6):288-94. doi: 10.1159/000331856. Epub 2011 Nov 10. Pharmacology. 2011. PMID: 22075549 Clinical Trial.

6

Effect of the P450 oxidoreductase 28 polymorphism on the pharmacokinetics of tacrolimus in Chinese healthy male volunteers.

Zhang JJ, Zhang H, Ding XL, Ma S, Miao LY. Zhang JJ, et al. Among authors: miao ly. Eur J Clin Pharmacol. 2013 Apr;69(4):807-12. doi: 10.1007/s00228-012-1432-1. Epub 2012 Oct 25. Eur J Clin Pharmacol. 2013. PMID: 23097010 Clinical Trial.

7

Development of second-generation small-molecule RhoA inhibitors with enhanced water solubility, tissue potency, and significant in vivo efficacy.

Ma S, Deng J, Li B, Li X, Yan Z, Zhu J, Chen G, Wang Z, Jiang H, Miao L, Li J. Ma S, et al. ChemMedChem. 2015 Jan;10(1):193-206. doi: 10.1002/cmdc.201402386. Epub 2014 Nov 5. ChemMedChem. 2015. PMID: 25377276

8

Discovery of benzylidene derivatives as potent Syk inhibitors: synthesis, SAR analysis, and biological evaluation.

Zhang L, Liu W, Mao F, Zhu J, Dong G, Jiang H, Sheng C, Miao L, Huang L, Li J. Zhang L, et al. Arch Pharm (Weinheim). 2015 Jul;348(7):463-74. doi: 10.1002/ardp.201500096. Epub 2015 Jun 1. Arch Pharm (Weinheim). 2015. PMID: 26032727

9

The structure of a small GTPaseRhoA in complex with PDZRhoGEF and the inhibitor HL47.

Yan Z, Ma S, Zhang Y, Ma L, Wang F, Li J, Miao L. Yan Z, et al. Biotechnol Lett. 2017 May;39(5):745-750. doi: 10.1007/s10529-017-2292-7. Epub 2017 Feb 1. Biotechnol Lett. 2017. PMID: 28150077

10

Evaluation of the in vitro Chemosensitivity and Correlation with Clinical Outcomes in Lung Cancer using the ATP-TCA.

Chen Z, Zhang S, Ma S, Li C, Xu C, Shen Y, Zhao J, Miao L. Chen Z, et al. Anticancer Agents Med Chem. 2018;18(1):139-145. doi: 10.2174/1871520617666170419123713. Anticancer Agents Med Chem. 2018. PMID: 28425853

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

203 results

Search Page

Filters